Genes Revealing Why Obesity Drugs Are More Effective for Some
Recent research has uncovered genetic factors that may explain the varied responses to obesity drugs among individuals. The study, published in *Nature*, draws on data from nearly 28,000 users of the DNA-testing service 23andMe. This extensive sample provides valuable insights into how genetics influence the effectiveness of weight-loss medications.
Genetic Variants and Weight Loss
Scientists identified specific genetic variants linked to weight loss and side effects from obesity medications. One variant is associated with enhanced weight reduction when using GLP-1 medications, which are designed to mimic natural hormones that regulate appetite and metabolism.
The research highlights that individuals with one copy of a certain genetic variant in the GLP-1 receptor gene lost, on average, 0.76 kilograms more during an eight-month treatment period compared to those without the variant. Those with two copies of this genetic variant demonstrated an even more significant weight loss, averaging around 1.5 kilograms more.
Insights into Side Effects
While the genetic impact on weight loss appears modest, the association between genetics and side effects like nausea is stronger. Co-author Adam Auton, the vice-president of human genetics at 23andMe Research Institute, emphasized that, although genetics play a role, numerous other factors affect weight loss outcomes.
Overview of GLP-1 Medications
Next-generation obesity medications, such as semaglutide, can greatly vary in their results among users. In trials, semaglutide demonstrated that some participants lost as much as 25% of their body weight, while others experienced minimal to no loss.
- Semaglutide: Mimics the hormone GLP-1.
- Tirzepatide: Mimics both GLP-1 and GIP hormones.
As numerous new obesity drugs are set to enter the market, understanding the genetic underpinnings of drug response will be crucial for personalized medicine. This research provides a stepping stone towards tailoring obesity treatments to individual genetic profiles.
